Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Inovio Pharmaceuticals, Inc. - Common Stock
(NQ:
INO
)
1.810
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inovio Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
↗
October 18, 2022
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Via
Benzinga
Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday
↗
October 17, 2022
The stock jumped Monday despite no news from the company.
Via
The Motley Fool
Inovio Pharma Highlights Early Data From Experimental Drug For Respiratory Tract Disease
↗
October 13, 2022
Via
Benzinga
RBC Capital Lowers Inovio Price Target As It Awaits This
↗
July 19, 2022
Via
Benzinga
Philips, Owens & Minor And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
↗
October 12, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Tesla, Credit Suisse And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
↗
October 03, 2022
U.S. stock futures traded mixed this morning after recording losses for the third quarter. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
↗
August 26, 2022
Via
Benzinga
Recap: Inovio Pharmaceuticals Q2 Earnings
↗
August 09, 2022
Inovio Pharmaceuticals (NASDAQ:INO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Inovio Lays Out Corporate Reorganization To Extend Cash Runway Into 2024
↗
July 19, 2022
Via
Benzinga
Why Inovio Pharmaceuticals Stock Is Rising Today
↗
May 23, 2022
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher Monday amid increasing monkeypox concerns.
Via
Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
↗
August 11, 2022
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
↗
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Two Appealing Biotech Stocks for Two Distinct investors
August 08, 2022
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
Via
MarketBeat
Topics
Intellectual Property
Does Amarin Deserve a Spot in Your Portfolio after Earnings ?
August 04, 2022
Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio.
Via
MarketBeat
Topics
Earnings
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
↗
August 01, 2022
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care...
Via
Benzinga
Monkeypox A Nationally Notifiable Condition, CDC Poised To Announce: Report
↗
July 28, 2022
Via
Benzinga
7 Monkeypox Stocks That May Take Off in Q2
↗
June 09, 2022
SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race.
Via
InvestorPlace
7 Monkeypox Stocks to Watch Right Now
↗
May 24, 2022
Wondering what are the best monkeypox stocks to watch? Here are the companies producing vaccines to help fight the spread of the virus.
Via
InvestorPlace
Morning Brief: Top Financial Stories Dominating on Tuesday, May 24
↗
May 24, 2022
CNBC
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
↗
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
WHO Says Monkeypox Outbreak 'Unusual' But 'Containable'
↗
May 24, 2022
The World Health Organization (WHO) said that there had been 131 confirmed monkeypox cases and 106 further suspected cases,
Via
Benzinga
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
↗
July 20, 2022
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...
Via
Benzinga
24 Stocks Moving in Monday's Pre-Market Session
↗
May 23, 2022
Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday.
Via
Benzinga
6 Stocks To Watch Amid Monkeypox Outbreak
↗
May 20, 2022
A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
May 19, 2022
It's time to tackle the biggest pre-market stock movers for this morning as we get ready for trading hours to start on Thursday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 11, 2022
Via
Benzinga
INO Stock Plunges 25% as Inovio Pharmaceuticals Swaps Vaccine Focus
↗
May 11, 2022
Inovio Pharmaceuticals has halted its Covid-19 progress to focus on a booster. Here's why this news is unlikely to boost INO stock.
Via
InvestorPlace
99 Biggest Movers From Yesterday
↗
May 12, 2022
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
Via
Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
↗
May 11, 2022
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022
↗
May 11, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today